Qube Research & Technologies (QRT)
ZBH icon

Qube Research & Technologies (QRT)’s Zimmer Biomet ZBH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-80,358
Closed -$8.49M – 3949
2024
Q4 		$8.49M Sell
80,358
-30,892
-28% -$3.31M 0.01% 1194
2024
Q3 		$12M Sell
111,250
-286,825
-72% -$31.3M 0.02% 921
2024
Q2 		$43.2M Buy
398,075
+397,462
+64,839% +$46.9M 0.07% 335
2024
Q1 		$80.9K Sell
613
-46,549
-99% -$5.81M ﹤0.01% 3380
2023
Q4 		$5.74M Sell
47,162
-469,433
-91% -$52.4M 0.01% 973
2023
Q3 		$58M Buy
+516,595
New +$65.6M 0.15% 177
2023
Q2 		– Sell
-209,760
Closed -$27.1M – 3115
2023
Q1 		$27.1M Buy
+209,760
New +$26.3M 0.12% 185
2022
Q1 		– Sell
-91,350
Closed -$11.3M – 3103
2021
Q4 		$11.3M Buy
91,350
+83,110
+1,009% +$10.9M 0.09% 309
2021
Q3 		$1.17M Sell
8,240
-17,627
-68% -$2.59M 0.01% 856
2021
Q2 		$4.04M Sell
25,867
-29,915
-54% -$4.85M 0.05% 476
2021
Q1 		$8.67M Sell
55,782
-10,481
-16% -$1.62M 0.14% 165
2020
Q4 		$9.91M Buy
66,263
+36,798
+125% +$5.2M 0.14% 153
2020
Q3 		$3.9M Sell
29,465
-34,286
-54% -$4.48M 0.06% 443
2020
Q2 		$7.39M Buy
+63,751
New +$7.35M 0.11% 237
2020
Q1 		– Sell
-3,535
Closed -$514K – 1745
2019
Q4 		$514K Buy
+3,535
New +$488K 0.02% 940
2019
Q2 		– Sell
-7,266
Closed -$901K – 583
2019
Q1 		$901K Buy
7,266
+2,787
+62% +$317K 0.12% 231
2018
Q4 		$451K Buy
4,479
+4,030
+898% +$453K 0.19% 138
2018
Q3 		$57K Buy
+449
New +$53.4K 0.01% 877

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ZBH Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 80,358 shares — an estimated $8.49M sold.

Qube Research & Technologies (QRT) first reported a position in ZBH in Q3 2018 and held it in 18 quarters. The position peaked at $58M in Q3 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 80,358 Zimmer Biomet shares in Q1 2025, an estimated $8.49M.
  • Qube Research & Technologies (QRT) first reported a position in Zimmer Biomet in Q3 2018 and held it in 18 quarters.
  • Qube Research & Technologies (QRT)'s Zimmer Biomet position peaked at $58M in Q3 2023.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.